19 October 2023
Ardian strengthens its commitment to Dedalus, driving the next phase of growth with a new investment and the appointment of a new Group CEO
A consortium led by Ardian, a world leading private investment house, has agreed to acquire an additional 19% stake in Dedalus, a leading European player in the healthcare software industry, from founder Giorgio Moretti. Subject to customary authorizations by the competent authorities, upon completion of the transaction, the consortium led by Ardian will indirectly hold a 92% stake in the Company, with Moretti retaining a 6% stake and a seat in the board.
7 June 2021
Dedalus announces a strategic partnership with Obviohealth to unite real world & clinical trial data
The partnership will unite Dedalus’s software solutions with ObvioHealth’s proprietary decentralized clinical trial tools.
1 June 2021
DEDALUS ACQUIRES OSM AG
One of the leading Laboratory Information Systems (LIS) companies in Germany.
27 May 2021
DEDALUS ACQUIRES DOSING, A LEADING SAAS MEDICATION SAFETY SOLUTIONS PROVIDER
Investing in clinical content to improve the quality and safety of care
1 April 2021
THE CREATION OF A GLOBAL FORCE IN HEALTHCARE IT
Dedalus Group, a leading international healthcare software provider, has announced that its acquisition of DXC’s healthcare provider software business is complete.